Literature DB >> 19156152

Effects of a neuregulin 1 variant on conversion to schizophrenia and schizophreniform disorder in people at high risk for psychosis.

S Kéri, I Kiss, O Kelemen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19156152     DOI： 10.1038/mp.2008.1

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN： 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  22 in total

Review 1.  Future classification of psychotic disorders.

Authors:  Wolfgang Gaebel; Jürgen Zielasek
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11       Impact factor: 5.270

2.  Whither the attenuated psychosis syndrome?

Authors:  Alison R Yung; Scott W Woods; Stephan Ruhrmann; Jean Addington; Frauke Schultze-Lutter; Barbara A Cornblatt; G Paul Amminger; Andreas Bechdolf; Max Birchwood; Stefan Borgwardt; Tyrone D Cannon; Lieuwe de Haan; Paul French; Paolo Fusar-Poli; Matcheri Keshavan; Joachim Klosterkötter; Jun Soo Kwon; Patrick D McGorry; Philip McGuire; Masafumi Mizuno; Anthony P Morrison; Anita Riecher-Rössler; Raimo K R Salokangas; Larry J Seidman; Michio Suzuki; Lucia Valmaggia; Mark van der Gaag; Stephen J Wood; Thomas H McGlashan
Journal:  Schizophr Bull       Date:  2012-11       Impact factor: 9.306

Review 3.  The neuregulin signaling pathway and schizophrenia: from genes to synapses and neural circuits.

Authors:  Andrés Buonanno
Journal:  Brain Res Bull       Date:  2010-08-03       Impact factor: 4.077

Review 4.  Positive Traits in the Bipolar Spectrum: The Space between Madness and Genius.

Authors:  Tiffany A Greenwood
Journal:  Mol Neuropsychiatry       Date:  2016-12-09

5.  Molecular and cellular characterization of Neuregulin-1 type IV isoforms.

Authors:  Alon Shamir; Andres Buonanno
Journal:  J Neurochem       Date:  2010-03-10       Impact factor: 5.372

6.  Lack of association to a NRG1 missense polymorphism in schizophrenia or bipolar disorder in a Costa Rican population.

Authors:  Emily Moon; Brandi Rollins; Andrea Mesén; Adolfo Sequeira; Richard M Myers; Huda Akil; Stanley J Watson; Jack Barchas; Edward G Jones; Alan Schatzberg; William E Bunney; Lynn E DeLisi; William Byerley; Marquis P Vawter
Journal:  Schizophr Res       Date:  2011-07-13       Impact factor: 4.939

7.  Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model.

Authors:  Francesco Papaleo; Feng Yang; Clare Paterson; Sara Palumbo; Gregory V Carr; Yanhong Wang; Kirsten Floyd; Wenwei Huang; Craig J Thomas; Jingshan Chen; Daniel R Weinberger; Amanda J Law
Journal:  J Neurosci       Date:  2016-04-27       Impact factor: 6.167

8.  Neuregulin links dopaminergic and glutamatergic neurotransmission to control hippocampal synaptic plasticity.

Authors:  Jörg Neddens; Detlef Vullhorst; Daniel Paredes; Andres Buonanno
Journal:  Commun Integr Biol       Date:  2009-05

9.  Behavioural characterization of neuregulin 1 type I overexpressing transgenic mice.

Authors:  Inga H Deakin; Amanda J Law; Peter L Oliver; Markus H Schwab; Klaus Armin Nave; Paul J Harrison; David M Bannerman
Journal:  Neuroreport       Date:  2009-11-25       Impact factor: 1.837

10.  The relationship among neuregulin 1-stimulated phosphorylation of AKT, psychosis proneness, and habituation of arousal in nonclinical individuals.

Authors:  Szabolcs Kéri; Imola Seres; Oguz Kelemen; György Benedek
Journal:  Schizophr Bull       Date:  2009-06-23       Impact factor: 9.306
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.